22,23,24 Improved performance of brain-targeted drug delivery was proved thanks to these materials with obvious advantages including non-invasive delivery, high drug loading, good biocompatibility, prolonged blood circulation, and importantly brain targeting effect
T2D is a progressive disease, and although some patients may manage it with oral medications, most will eventually need to use insulin to achieve glycemic control
According to Truveta Research presented at ISPOR 2025, side effects were the leading reason patients stopped taking GLP-1 medications, accounting for 28.2% of all discontinuations
Pregnancy and Breastfeeding: Safe under medical supervision, but consult your doctor before use
Garrett Q, Xu S, Simmons PA, Vehige J, Flanagan JL, Willcox MD
J Investig Med High Impact Case Rep